Hemodynamic management of septic shock

被引:3
作者
Lipcsey, M. [1 ]
Castegren, M. [2 ]
Bellomo, R. [3 ,4 ]
机构
[1] Uppsala Univ, Sect Anesthesiol & Intens Care, Dept Surg Sci, Uppsala, Sweden
[2] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden
[3] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia
[4] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Alfred Ctr, Melbourne, Vic 3004, Australia
关键词
Shock; septic; Fluid therapy; Catecholamines; Vasoconstrictor agents; Hemodynamics; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; VENOUS OXYGEN-SATURATION; VENA-CAVA DIAMETER; SEVERE SEPSIS; FLUID RESPONSIVENESS; CARDIAC-OUTPUT; LACTATE CLEARANCE; BLOOD-PRESSURE; PERFUSION PARAMETERS;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We present a review of the hemodynamic management of septic shock. Although substantial amount of evidence is present in this area, most key decisions on the management of these patients remain dependent on physiological reasoning and on pathophysiological principles rather than randomized controlled trials. During primary (early) resuscitation, restoration of adequate arterial pressure and cardiac output using fluids and vasopressor and/or inotropic drugs is guided by basic hemodynamic monitoring and physical examination in the emergency department. When more advanced level of monitoring is present in these patients, i.e. during secondary resuscitation (later phase in the emergency department and in the ICU), hemodynamic management can be guided by more advanced measurements of the macrocirculation. Our understanding of the microcirculation in septic shock is limited and reliable therapeutic modalities to optimize it do not yet exist. No specific hemodynamic treatment strategy; be it medications including fluids, monitoring devices or treatment algorithms has yet been proved to improve outcome. Moreover, there is virtually no data on the optimal management of the resolution phase of septic shock. Despite these gaps in knowledge, the data from observational studies and trials suggests that mortality in septic shock has been generally decreasing during the last decade.
引用
收藏
页码:1262 / 1272
页数:11
相关论文
共 107 条
  • [1] A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock
    Alía, I
    Esteban, A
    Gordo, F
    Lorente, JA
    Diaz, C
    Rodriguez, JA
    Frutos, F
    [J]. CHEST, 1999, 115 (02) : 453 - 461
  • [2] Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623
  • [3] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [4] Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial
    Annane, Djillali
    Vignon, Philippe
    Renault, Alain
    Bollaert, Pierre-Edouard
    Charpentier, Claire
    Martin, Claude
    Troche, Gilles
    Ricard, Jean-Damien
    Nitenberg, Gerard
    Papazian, Laurent
    Azoulay, Elie
    Bellissant, Eric
    [J]. LANCET, 2007, 370 (9588) : 676 - 684
  • [5] Antonucci E, 2014, MINERVA ANESTESIOL, V80, P1058
  • [6] Asfar P., 2014, N ENGL J MED
  • [7] Patient and hospital characteristics associated with inpatient severe sepsis mortality in California, 2005-2010
    Banta, Jim E.
    Joshi, Kamlesh P.
    Beeson, Lawrence
    Nguyen, H. Bryant
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (11) : 2960 - 2966
  • [8] Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients
    Barbier, C
    Loubières, Y
    Schmit, C
    Hayon, J
    Ricôme, JL
    Jardin, FO
    Vieillard-Baron, A
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (09) : 1740 - 1746
  • [9] Bellomo R, 2000, LANCET, V356, P2139
  • [10] Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis
    Bellomo, Rinaldo
    Lipcsey, Miklos
    Calzavacca, Paolo
    Haase, Michael
    Haase-Fielitz, Anjia
    Licari, Elisa
    Tee, Augustine
    Cole, Louise
    Cass, Alan
    Finfer, Simon
    Gallagher, Martin
    Lee, Joanne
    Lo, Serigne
    McArthur, Colin
    McGuinness, Shay
    Myburgh, John
    Scheinkestel, Carlos
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (03) : 429 - 436